Results 161 to 170 of about 355,372 (304)
Mechanism of LCN2 in cerebral ischemia-reperfusion injury. [PDF]
Cai LY+5 more
europepmc +1 more source
Failure of the somatosensory evoked potential following middle cerebral artery occlusion and high-grade ischemia in the cat--effects of hemodilution. [PDF]
Philip E. Coyer+3 more
openalex +1 more source
Abstract Sodium‐glucose co‐transporters (SGLTs) mediate sodium and glucose transport across cell membranes. SGLT2 inhibitors have a recognized place within heart failure (HF) guidelines. We evaluated the effect of sotagliflozin on HF and cardiovascular outcomes in participants with type 2 diabetes. Scopus, Medline, Embase and Central were searched from
Maria Anna Bantounou+7 more
wiley +1 more source
The clinical significance of artery of Percheron in cerebral ischemia: a summary overview. [PDF]
Kashif M+4 more
europepmc +1 more source
Role of central aminergic fibers in experimental cerebral ischemia in stroke-prone SHR. Relation to anesthetic effect. [PDF]
Ichiro Akiguchi+2 more
openalex +1 more source
RHBDF2 governs microglial neuroinflammation during cerebral ischemia-reperfusion injury and is positively regulated by the m6A reader YTHDF1. [PDF]
Xu L+5 more
europepmc +1 more source
Tolerance of the cerebral venous system to retrograde perfusion pressure in focal cerebral ischemia in rats. [PDF]
Takashi Ueda+3 more
openalex +1 more source
Abstract Aims Immune checkpoint inhibitors (ICI) are the cornerstone of modern oncology; however, side effects such as ICI‐related myocarditis (irM) can be fatal. Recently, Bonaca proposed criteria for irM; however, it is unknown if they correlate well with cardiovascular (CV) ICI‐related adverse events.
Lorenzo Braghieri+12 more
wiley +1 more source